KBC Group NV Increases Stake in USANA Health Sciences, Inc. (NYSE:USNA)

KBC Group NV lifted its stake in USANA Health Sciences, Inc. (NYSE:USNA) by 96.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,056 shares of the company’s stock after purchasing an additional 519 shares during the quarter. KBC Group NV’s holdings in USANA Health Sciences were worth $40,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Pzena Investment Management LLC grew its holdings in shares of USANA Health Sciences by 24.4% during the 2nd quarter. Pzena Investment Management LLC now owns 976,633 shares of the company’s stock worth $44,183,000 after purchasing an additional 191,289 shares during the period. Dimensional Fund Advisors LP grew its stake in USANA Health Sciences by 0.6% during the 2nd quarter. Dimensional Fund Advisors LP now owns 683,158 shares of the company’s stock worth $30,907,000 after purchasing an additional 3,889 shares in the last quarter. Pacer Advisors Inc. grew its position in shares of USANA Health Sciences by 14.3% during the second quarter. Pacer Advisors Inc. now owns 467,352 shares of the company’s stock worth $21,143,000 after buying an additional 58,597 shares in the last quarter. American Century Companies Inc. increased its stake in shares of USANA Health Sciences by 12.3% during the second quarter. American Century Companies Inc. now owns 159,782 shares of the company’s stock worth $7,229,000 after buying an additional 17,460 shares during the period. Finally, Assenagon Asset Management S.A. grew its stake in shares of USANA Health Sciences by 13.5% during the third quarter. Assenagon Asset Management S.A. now owns 124,008 shares of the company’s stock worth $4,702,000 after purchasing an additional 14,756 shares in the last quarter. 54.25% of the stock is owned by institutional investors and hedge funds.

USANA Health Sciences Stock Up 1.4 %

USNA opened at $39.90 on Friday. The business has a 50 day moving average price of $37.83 and a two-hundred day moving average price of $41.73. USANA Health Sciences, Inc. has a 52 week low of $34.15 and a 52 week high of $54.81. The company has a market cap of $760.49 million, a PE ratio of 14.10, a P/E/G ratio of 1.34 and a beta of 0.89.

USANA Health Sciences (NYSE:USNA) last released its earnings results on Tuesday, October 22nd. The company reported $0.56 EPS for the quarter, beating analysts’ consensus estimates of $0.49 by $0.07. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. The company had revenue of $200.22 million during the quarter, compared to the consensus estimate of $208.45 million. During the same quarter last year, the company earned $0.59 earnings per share. As a group, sell-side analysts expect that USANA Health Sciences, Inc. will post 2.45 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, DA Davidson cut their price target on shares of USANA Health Sciences from $38.00 to $35.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 23rd.

Insiders Place Their Bets

In other USANA Health Sciences news, Director Gilbert A. Fuller sold 675 shares of the company’s stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $37.71, for a total value of $25,454.25. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.33% of the stock is owned by company insiders.

USANA Health Sciences Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.